Abstract
Chemotherapy-Free Combination of Obinutuzumab and Ibrutinib in First LINE Treatment of Follicular Lymphoma. the Alternative Study By the German Low Grade Lymphoma Study Group (GLSG)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have